Access, utilization and outcomes of cancer services in the ERA of telemedicine

Active Project Grant Awarded Last action

Award ID
R01CA267990
Recipient
Awarding agency
Obligated
$5,372,510

Award facts

Assistance listing
93.393 Cancer Cause and Prevention Research
Completion date 95% complete
Funding
  • $4,985,938.00 Federal
  • $386,572.00 Non-federal
Place of performance
Salt Lake City, UT 84112, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Use of telehealth has skyrocketed since the start of the covid-19 pandemic. Pre-pandemic, only 60,000 of the 63 million fee-for-service medicare beneficiaries received a telehealth service each month compared to 24.5 million from march to october, 2020, with wide geographic variation in that uptake (e.g. 8.4% in south dakota to 47.6% in massachusetts). This telehealth expansion comes at a time when the often-severe access issues for rural individuals have become a focus for health policy and equity. Longer travel times for rural cancer patients have been shown to negatively impact treatment regimens, RCT participation, and symptom management. Multi-specialist teams are often required for comprehensive cancer care, making care coordination in rural areas particularly challenging. These barriers have contributed to the widening GAP in cancer mortality between rural and urban patients. Measuring access to cancer care is a fundamental component of both identifying gaps in access, as well as developing care delivery models to mitigate disparities. Because telehealth transcends geographic proximity, IT holds great promise for addressing rural cancer care access inequities. Telehealth allows specialists to connect with geographically distant patients and providers who otherwise would have had more restricted options for referral. With the expected persistence of expanded telehealth following the covid-19 pandemic, the time is now to develop new ways to measure access to cancer care that integrate geospatial measures with telehealth and referral patterns in order to improve equity in health care access and outcomes. Telehealth is now integral to rural cancer care in some regions, yet where gaps are in its use and how inequities in access impact utilization and outcomes is unknown. Only by measuring the new reality of cancer care access that includes telehealth, understanding telehealth impacts on outcomes, and applying this evidence to "what if" scenarios/projections, can we begin to harness and proactively direct the potential that telehealth has to reduce rural cancer disparities. This study will take the critical and timely steps of developing measures of access nationally that incorporate telehealth, identifying determinants of telehealth use in cancer care, testing effects of telehealth on cancer outcomes, and analyzing the projected impact on equity in cancer care access and outcomes if telehealth use in cancer is expanded, while considering differential effects based on the rural-urban continuum. To do this, we will use national medicare claims for telehealth utilization among cancer patients, federal communications commission (FCC) broadband data, and 2020 census data for the entire U.S., to extend our prior geospatial cancer care access work (R21CA212687) and population-based outcomes modeling with policy relevance.

Transactions

Action Federal Non-federal Date
Amendment $35,962 $0
Amendment $323,658 $0
Amendment $323,658 $0
Amendment $36,020 $0
Amendment $36,020 $0
Amendment $324,186 $0
Amendment $324,186 $0
Amendment $18,114 $0
Amendment $18,114 $0
Amendment $18,114 $0
Amendment $326,051 $0
Amendment $326,051 $0
Amendment $326,051 $0
Amendment $326,051 $0
Amendment $354,662 $0
Amendment $354,662 $0
Amendment $354,662 $0
Amendment $386,572 $0
Amendment $386,572 $386,572
Original award $386,572 $0
Show all 20

Subawards

Subrecipient Amount Awarded
Louisiana State University In Shreveport Access, Utilization and outcomes of cancer services in the era of telemedicine $265,140
Trustees Of Dartmouth College Access, utilization and outcomes of cancer services in the ERA of telemedicine $816,308

Quick answers

Who received award R01CA267990?

R01CA267990 was awarded to University Of Utah by National Cancer Institute (National Institutes of Health) on February 1, 2022.

How much is award R01CA267990 worth?

$5,372,510 has been obligated on R01CA267990: $4,985,938 in federal funding and $386,572 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login